Home › Funds › Ranmore Fund Management Ltd › REGN

Ranmore Fund Management Ltd position in REGN

REGENERON PHARMACEUTICALS · Health Care

Ranmore Fund Management Ltd reported holding 30,000 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$18.7M, representing 2.07% of its reported portfolio and ranking #20 among its reported holdings. Ranmore Fund Management Ltd first reported this position in Q2 2026.

Latest position (Q2 2026)30.00K sh
Reported value held$18.71M
Portfolio Weight2.07%
First reportedQ2 2026
Last changeNew

How Ranmore Fund Management Ltd's REGN position evolved

Ranmore Fund Management Ltd first disclosed a stake in REGN in Q2 2026 at 30,000 shares (US$18.7M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 30.00K $18.71M New

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Vanguard Group (US$7.00B), BlackRock Inc (US$5.68B), VANGUARD CAPITAL MANAGEMENT LLC (US$4.13B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →